A detailed history of Southern Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Southern Capital Advisors, LLC holds 5,656 shares of MRK stock, worth $565,939. This represents 0.37% of its overall portfolio holdings.

Number of Shares
5,656
Previous 4,598 23.01%
Holding current value
$565,939
Previous $569,000 12.83%
% of portfolio
0.37%
Previous 0.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$111.15 - $128.97 $117,596 - $136,450
1,058 Added 23.01%
5,656 $642,000
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $8,294 - $8,908
-67 Reduced 1.44%
4,598 $569,000
Q1 2024

May 03, 2024

BUY
$113.24 - $131.95 $30,235 - $35,230
267 Added 6.07%
4,665 $615,000
Q4 2023

Jan 22, 2024

BUY
$100.18 - $109.02 $14,425 - $15,698
144 Added 3.39%
4,398 $479,000
Q3 2023

Oct 31, 2023

SELL
$102.95 - $114.33 $1.52 Million - $1.69 Million
-14,807 Reduced 77.68%
4,254 $437,000
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $135,002 - $147,146
-1,243 Reduced 6.12%
19,061 $2.2 Million
Q1 2023

Apr 27, 2023

BUY
$102.94 - $114.86 $129,910 - $144,953
1,262 Added 6.63%
20,304 $2.16 Million
Q4 2022

Jan 20, 2023

BUY
$87.44 - $112.11 $199,800 - $256,171
2,285 Added 13.64%
19,042 $0
Q3 2022

Oct 20, 2022

BUY
$84.53 - $94.96 $136,769 - $153,645
1,618 Added 10.69%
16,757 $1.44 Million
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $572,490 - $648,946
6,857 Added 82.79%
15,139 $1.38 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $3,601 - $4,037
49 Added 0.6%
8,282 $680,000
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $595,081 - $745,415
8,233 New
8,233 $631,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Southern Capital Advisors, LLC Portfolio

Follow Southern Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Southern Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Southern Capital Advisors, LLC with notifications on news.